Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 46
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

What is known about the efficacy and safety of tech products for reproductive health?

FemTech describes technology to improve women's health. From ovulation bracelets to pelvic floor therapy...

Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

Backer Badge Funded